In the treatment of HCC, cinobufotalin has been found to reduce the mRNA and protein expression of β-catenin, as well as its target genes MMP7 and dickkopf WNT signaling pathway inhibitor 1 (DKK1), which are associated with tumor invasion and metastasis [205]. The gene discussed is DKK1; the disease is hepatocellular carcinoma.